Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01546285 · ClinicalTrials.gov registry record · NA
B40 Non-Invasive Blood Pressure Equivalency Study
A NA study, sponsored by GE Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 66
- Enrollment target
NCT01546285 is a NA study that has completed, run by GE Healthcare. The registered enrollment target is 66 participants.
The verdict
NCT01546285, a NA study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 66 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate equivalency of the GE Healthcare B40 Patient Monitor noninvasive blood pressure (NIBP) parameter compared to the reference device.
Interventions
- DEVICE Blood Pressure Readings on B40 Patient Monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01546285
The ClinicalTrials.gov registry entry for NCT01546285 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood Pressure Readings on B40 Patient Monitor is the first listed.
NCT01546285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01546285 about?
NCT01546285 is a clinical study titled "B40 Non-Invasive Blood Pressure Equivalency Study". The purpose of this study is to demonstrate equivalency of the GE Healthcare B40 Patient Monitor noninvasive blood pressure (NIBP) parameter compared to the reference device.
What is the current status of trial NCT01546285?
This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2012-03. Estimated completion is 2012-03.
What interventions are being tested in trial NCT01546285?
The interventions under investigation include: Blood Pressure Readings on B40 Patient Monitor (DEVICE).
Who is sponsoring clinical trial NCT01546285?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.